C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH), also known as N-(4-Hydroxymethylbenzyl) Cyclam, is a compound that serves as an impurity in Plerixafor (P580500). Plerixafor is a hematopoietic stem cell (HSC) mobilizer that inhibits the CXCR4 chemokine receptor and blocks the binding of its ligand, stromal cell-derived factor-1-α (SDF-1-α). N-(4-Hydroxymethylbenzyl) Cyclam is characterized by its molecular structure and its role in the pharmaceutical industry.

176252-20-3

Post Buying Request

Basic information
1. Product Name: C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH)
2. Synonyms:
3. CAS NO:176252-20-3
4. Molecular Formula:
5. Molecular Weight: 320.478
6. EINECS: N/A
7. Product Categories: N/A
Chemical Properties
1. Melting Point: N/A
2. Boiling Point: 496.9±45.0 °C(Predicted)
3. Flash Point: N/A
4. Appearance: N/A
5. Density: 1.002±0.06 g/cm3(Predicted)
6. Refractive Index: N/A
7. Storage Temp.: N/A
8. Solubility: N/A
9. CAS DataBase Reference: C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH)(CAS DataBase Reference)
10. NIST Chemistry Reference: C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH)(176252-20-3)
11. EPA Substance Registry System: C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH)(176252-20-3)
Safety Data
1. Hazard Codes: N/A
2. Statements: N/A
3. Safety Statements: N/A
4. WGK Germany:
5. RTECS:
6. HazardClass: N/A
7. PackingGroup: N/A
8. Hazardous Substances Data: 176252-20-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products

176252-20-3 Suppliers

Recommended suppliers

176252-20-3 Usage

Uses

1. Used in Pharmaceutical Industry:
C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH) is used as an impurity in Plerixafor, a hematopoietic stem cell mobilizer, for the inhibition of the CXCR4 chemokine receptor and the blocking of SDF-1-α binding.
2. Used in Hematopoietic Stem Cell Mobilization:
C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH) is used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).
3. Used in Cancer Treatment:
C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH) is utilized in the development and application of Plerixafor, which is approved for use in combination with G-CSF to mobilize HSCs for transplantation in patients with NHL and MM, contributing to the treatment of these types of cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 176252-20-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,2,5 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 176252-20:
(8*1)+(7*7)+(6*6)+(5*2)+(4*5)+(3*2)+(2*2)+(1*0)=133
133 % 10 = 3
So 176252-20-3 is a valid CAS Registry Number.

176252-20-3Upstream product

176252-20-3Downstream Products

176252-19-0 Mo(CO)3(C₁₀H₂₃N₄(CH₂C₆H₄CH₂OH))

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 176252-20-3